Brief: CareDx's Allosure Lung dd-cfDNA Testing Service Receives Medicare Coverage For Lung Transplant Rejection Monitoring
11/07/2023 12:07
July 11 (Reuters) - CareDx Inc CDNA.O :
* CAREDX’S ALLOSURE LUNG DD-CFDNA TESTING SERVICE RECEIVES
MEDICARE COVERAGE FOR LUNG TRANSPLANT REJECTION MONITORING
Source text for Eikon: ID:nBw4P1pgPa
Further company coverage: CDNA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on CareDx
See all newsBrief: Caredx Announces New Koar Data Linking Elevated Allosure® Kidney To Nearly 3-Fold Higher Risk Of Adverse Graft Outcomes In Patients With Borderline Rejection Or Tcmr At Asn Kidney Week 2026
US RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
CareDx Inc reports results for the quarter ended June 30 - Earnings Summary
CareDx Q2 revenue beats estimates; outlook lifted
Brief: CareDx Q2 Adjusted EPS USD 0.37 Vs. IBES Estimate USD 0.23